Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To estimate the efficacy of ipatasertib combined with paclitaxel compared with placebo combined with paclitaxel in patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC), as measured by progression free survival (PFS) in all patients and in patients with PTEN low tumors
Critère d'inclusion
- Inoperable locally advanced or metastatic triple negative breast cancer